Sirnaomics Licenses Polypeptide Nanoparticle Delivery Technology from University of Maryland Medical School

The company said the deal gives it access to the technology in the areas of wound healing and ocular diseases.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.